Loading…
Responsibility in Drug Advertising Act of 2016
Legislative Progress
Introduced
February 12, 2016
Latest Action
February 19, 2016
Primary Sponsor
Rosa L. DeLauroDemocratic(CT)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
43pct
7d open
vs 6,526 other HR bills in the 114th — cohort avg 56d
Responsibility in Drug Advertising Act of 2016 This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit direct-to-consumer advertising of a drug in the first three years after the drug's approval. The Food and Drug Administration may: (1) waive the third year of this prohibition for a drug if direct-to-consumer advertising of the drug would have an affirmative value to public health, or (2) extend the prohibition if the drug has significant adverse health effects.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (6)
2016 · fourth_quarter · Advertising
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Legislation or regulations affecting the tax treatment of advertising, including but not limited to opposing proposals to limit or eliminate the federal business tax deduction for advertising expenses. Oppose legislation or regulations which would prohibit or restrict the truthful advertising of legal products or services. HR 4565 The Responsibility in Drug Advertising Act - oppose
Client expense: $30,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Pharmacy
Proposals relating to the regulation of direct to consumer prescription drug advertising H.R. 4565, Responsibility in Drug Advertising Act of 2016, to prohibit for three years after FDA approval direct to consumer prescription drug advertising
Client expense: $420,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Advertising
Issues relating to tax deductibility of certain advertising expenditures. H.R.2125, Keeping Our Campaigns Honest Act of 2015, all provisions. H.R.4179, Fair and Clear Campaign Transparency Act, all provisions. H.R.4565, Responsibility in Drug Advertising Act of 2016, provisions relating to the restriction of direct-to-consumers drug advertising. S.1260, Sunshine in Sponsorship Identification Act, all provisions. S.2623, Protecting Americans from Drug Marketing Act, provisions relating to denying the deduction for advertising and promotional expenses for prescription drugs.
Client expense: $4,280,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Advertising
HR.478, "Protecting Children from Electronic Cigarette Advertising Act of 2015, all provisions related to broadcasting H.R.4565, Responsibility in Drug Advertising Act of 2016, all provisions S.430, Protecting Children from Electronic Cigarette Advertising Act of 2015," all provisions related to broadcasting S.2623, Protecting Americans from Drug Marketing Act, all provisions
Client expense: $990,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Advertising
H.R. 478: Protecting Children from Electronic Cigarette Advertising Act; H.R. 537: Truth in Obamacare Advertising Act of 2015, provision related to commercial speech images; S. 2623: Protecting Americans from Drug Marketing Act; H.R.4565: Responsibility In Drug Advertising Act
Client expense: $150,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Postal Regulatory Commission, SENATE, Treasury, Dept of, U.S. Postal Service (USPS)
2016 · fourth_quarter · Advertising
A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015 H.R. 4565, Responsibility in Drug Advertising Act of 2016 S. 2623, Protecting Americans from Drug Marketing Act H.R. 6043/S. 3335, FAIR Drug Pricing Act FTC Reauthorization Act of 2016 (Not introduced)
Client expense: Not reported · Firm income: $170,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Advertising
HR.478, "Protecting Children from Electronic Cigarette Advertising Act of 2015, all provisions related to broadcasting H.R.4565, Responsibility in Drug Advertising Act of 2016, all provisions S.430, Protecting Children from Electronic Cigarette Advertising Act of 2015," all provisions related to broadcasting S.2623, Protecting Americans from Drug Marketing Act, all provisions
Client expense: $830,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Advertising
Issues relating to tax deductibility of certain advertising expenditures. H.R.2125, Keeping Our Campaigns Honest Act of 2015, all provisions. H.R.4179, Fair and Clear Campaign Transparency Act, all provisions. H.R.4565, Responsibility in Drug Advertising Act of 2016, provisions relating to the restriction of direct-to-consumers drug advertising. S.1260, Sunshine in Sponsorship Identification Act, all provisions. S.2623, Protecting Americans from Drug Marketing Act, provisions relating to denying the deduction for advertising and promotional expenses for prescription drugs.
Client expense: $3,770,000 · Firm income: Not reported
2016 · third_quarter · Advertising
Legislation or regulations affecting the tax treatment of advertising, including but not limited to opposing proposals to limit or eliminate the federal business tax deduction for advertising expenses. Oppose legislation or regulations which would prohibit or restrict the truthful advertising of legal products or services. HR 4565 The Responsibility in Drug Advertising Act - oppose
Client expense: $30,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Advertising
H.R. 478: Protecting Children from Electronic Cigarette Advertising Act; H.R. 537: Truth in Obamacare Advertising Act of 2015, provision related to commercial speech images; S. 2623: Protecting Americans from Drug Marketing Act; H.R.4565: Responsibility In Drug Advertising Act
Client expense: $150,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Postal Regulatory Commission, SENATE, Treasury, Dept of, U.S. Postal Service (USPS)
2016 · third_quarter · Pharmacy
Proposals relating to the regulation of direct to consumer prescription drug advertising H.R. 4565, Responsibility in Drug Advertising Act of 2016, to prohibit for three years after FDA approval direct to consumer prescription drug advertising
Client expense: $420,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Advertising
A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015 H.R. 4565, Responsibility in Drug Advertising Act of 2016 S. 2623, Protecting Americans from Drug Marketing Act FTC Reauthorization Act of 2016 (Not introduced)
Client expense: Not reported · Firm income: $170,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Advertising
H.R. 478: Protecting Children from Electronic Cigarette Advertising Act; H.R. 537: Truth in Obamacare Advertising Act of 2015, provision related to commercial speech images; S. 2623: Protecting Americans from Drug Marketing Act; H.R.4565: Responsibility In Drug Advertising Act
Client expense: $150,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Postal Regulatory Commission, SENATE, Treasury, Dept of, U.S. Postal Service (USPS)
2016 · second_quarter · Advertising
HR.478, "Protecting Children from Electronic Cigarette Advertising Act of 2015, all provisions related to broadcasting H.R.4565, Responsibility in Drug Advertising Act of 2016, all provisions S.430, Protecting Children from Electronic Cigarette Advertising Act of 2015," all provisions related to broadcasting S.2623, Protecting Americans from Drug Marketing Act, all provisions
Client expense: $840,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Advertising
Issues relating to tax deductibility of certain advertising expenditures. H.R.2125, Keeping Our Campaigns Honest Act of 2015, all provisions. H.R.4179, Fair and Clear Campaign Transparency Act, all provisions. H.R.4565, Responsibility in Drug Advertising Act of 2016, provisions relating to the restriction of direct-to-consumers drug advertising. S.1260, Sunshine in Sponsorship Identification Act, all provisions. S.2623, Protecting Americans from Drug Marketing Act, provisions relating to denying the deduction for advertising and promotional expenses for prescription drugs.
Client expense: $3,610,000 · Firm income: Not reported
2016 · second_quarter · Advertising
Legislation or regulations affecting the tax treatment of advertising, including but not limited to opposing proposals to limit or eliminate the federal business tax deduction for advertising expenses. Oppose legislation or regulations which would prohibit or restrict the truthful advertising of legal products or services. HR 4565 The Responsibility in Drug Advertising Act - oppose
Client expense: $30,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Pharmacy
Proposals relating to the regulation of direct to consumer prescription drug advertising H.R. 4565, Responsibility in Drug Advertising Act of 2016, to prohibit for three years after FDA approval direct to consumer prescription drug advertising
Client expense: $420,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Advertising
A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015 H.R. 4565, Responsibility in Drug Advertising Act of 2016 S. 2623, Protecting Americans from Drug Marketing Act FTC Reauthorization Act of 2016 (Not introduced)
Client expense: Not reported · Firm income: $170,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · first_quarter · Advertising
H.R. 478: Protecting Children from Electronic Cigarette Advertising Act; H.R. 573: Truth in Obamacare Advertising Act of 2015, provision related to commercial speech images; S. 2623: Protecting Americans from Drug Marketing Act; H.R.4565: Responsibility In Drug Advertising Act
Client expense: $130,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Postal Regulatory Commission, SENATE, Treasury, Dept of, U.S. Postal Service (USPS)
2016 · first_quarter · Advertising
HR.478, "Protecting Children from Electronic Cigarette Advertising Act of 2015, all provisions related to broadcasting H.R.4565, Responsibility in Drug Advertising Act of 2016, all provisions S.430, Protecting Children from Electronic Cigarette Advertising Act of 2015," all provisions related to broadcasting S.2623, Protecting Americans from Drug Marketing Act, all provisions
Client expense: $1,810,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
2016 · first_quarter · Advertising
Issues relating to tax deductibility of certain advertising expenditures. H.R.2125, Keeping Our Campaigns Honest Act of 2015, all provisions. H.R.4179, Fair and Clear Campaign Transparency Act, all provisions. H.R.4565, Responsibility in Drug Advertising Act of 2016, provisions relating to the restriction of direct-to-consumers drug advertising. S.1260, Sunshine in Sponsorship Identification Act, all provisions. S.2623, Protecting Americans from Drug Marketing Act, provisions relating to denying the deduction for advertising and promotional expenses for prescription drugs.
Client expense: $4,738,000 · Firm income: Not reported
2016 · first_quarter · Pharmacy
Proposals relating to the regulation of direct to consumer prescription drug advertising H.R. 4565, Responsibility in Drug Advertising Act of 2016, to prohibit for three years after FDA approval direct to consumer prescription drug advertising
Client expense: $460,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
2016 · first_quarter · Advertising
Legislation or regulations affecting the tax treatment of advertising, including but not limited to opposing proposals to limit or eliminate the federal business tax deduction for advertising expenses. Oppose legislation or regulations which would prohibit or restrict the truthful advertising of legal products or services. HR 4565 The Responsibility in Drug Advertising Act - oppose
Client expense: $30,000 · Firm income: Not reported
Government targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2016 · first_quarter · Advertising
A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015 H.R. 4565, Responsibility in Drug Advertising Act of 2016 S. 2623, Protecting Americans from Drug Marketing Act FTC Reauthorization Act of 2016 (Not introduced)
Client expense: Not reported · Firm income: $170,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · first_quarter · Advertising
A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015 H.R. 4565, Responsibility in Drug Advertising Act of 2016 S. 2623, Protecting Americans from Drug Marketing Act FTC Reauthorization Act of 2016 (Not introduced)
Client expense: Not reported · Firm income: $170,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Copyright Office